Short Communications 3
Depression 1 - Clinical (1)

[SC3-1] Subgroup Analysis in Changes in Quality of Life and Depression Severity Scores By Line of Therapy in Patients Treated with Esketamine in a Real-world Setting across ANZ

*David Barton³, Andrea Puig², Jarrad King², Ian Hickie¹ (1. Brain and Mind Centre, The University of Sydney, Sydney, Australia, 2. Janssen, Sydney, NSW, Australia, 3. Neurocentrix, Noble Park, Melbourne, Australia)

Keywords:major depressive disorder, esketamine, real-world evidence, quality of life